Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.641 | 0.600 | 6 | 31572536 | intron variant | A/G;T | snv |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 2015 | 2019 | ||||||||
|
0.641 | 0.600 | 6 | 31572536 | intron variant | A/G;T | snv |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2012 | 2018 | ||||||||
|
0.641 | 0.600 | 6 | 31572536 | intron variant | A/G;T | snv |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.020 | 0.500 | 2 | 2006 | 2019 | ||||||||
|
0.641 | 0.600 | 6 | 31572536 | intron variant | A/G;T | snv |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2015 | 2018 | ||||||||
|
0.641 | 0.600 | 6 | 31572536 | intron variant | A/G;T | snv |
|
Cardiovascular Diseases | 0.020 | 0.500 | 2 | 2006 | 2013 | ||||||||
|
0.641 | 0.600 | 6 | 31572536 | intron variant | A/G;T | snv |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2012 | 2018 | ||||||||
|
0.882 | 0.080 | 6 | 31573570 | synonymous variant | C/T | snv | 4.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.882 | 0.080 | 6 | 31573570 | synonymous variant | C/T | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.882 | 0.080 | 6 | 31573570 | synonymous variant | C/T | snv | 4.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.882 | 0.080 | 6 | 31573570 | synonymous variant | C/T | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.882 | 0.080 | 6 | 31573570 | synonymous variant | C/T | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
6 | 31567356 | upstream gene variant | G/A | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
1.000 | 0.120 | 6 | 31562106 | downstream gene variant | C/G;T | snv |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | ||||||||
|
1.000 | 0.040 | 6 | 31561557 | downstream gene variant | C/G;T | snv |
|
Stomatognathic Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
6 | 31559979 | downstream gene variant | G/A;C | snv |
|
Nervous System Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | ||||||||||
|
6 | 31563033 | downstream gene variant | G/A;C | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
6 | 31572652 | intron variant | C/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
6 | 31572652 | intron variant | C/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
0.641 | 0.600 | 6 | 31572536 | intron variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.641 | 0.600 | 6 | 31572536 | intron variant | A/G;T | snv |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.641 | 0.600 | 6 | 31572536 | intron variant | A/G;T | snv |
|
Infections; Immune System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.641 | 0.600 | 6 | 31572536 | intron variant | A/G;T | snv |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.641 | 0.600 | 6 | 31572536 | intron variant | A/G;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.641 | 0.600 | 6 | 31572536 | intron variant | A/G;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.641 | 0.600 | 6 | 31572536 | intron variant | A/G;T | snv |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 |